EN
HI
Astrazeneca Pharma India share price chart
Astrazeneca Pharma India Share Key Metrics
Volume
47975.00
Market Cap
20225.00 CR
LTQ@LTP
1@8090.00
ATP
8046.58
Var Margin
15.18 %
Circuit Range
6472-9708
Delivery %
29.92 %
Value
38.60 CR
ASM/GSM
No
Market Lot
1
Summary
ASTRAZEN stock price is ₹8090 as of 11 Aug, 2026. The stock intraday movement has stayed between ₹7722.00 and ₹8259.00, while Astrazeneca Pharma India share price 52 week high low is ₹7551.50 & ₹9849.50.
In terms of trading activity, ASTRAZEN share price has recorded a volume of 47,975 shares. The Astrazeneca Pharma India has a market cap of ₹25000000. The stock’s Average Traded Price (ATP) stands at ₹8046.58, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹8090.00.
The Astrazeneca Pharma India upper circuit limit is ₹9708.00 & The Astrazeneca Pharma India lower circuit limit is ₹6472.00, with a Value of ₹38.60 CR. The Delivery Percentage for the day is 29.92%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Astrazeneca Pharma India Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
64.83
Sector P/B
3.28
Sec. Div. Yield
0.51
Astrazeneca Pharma India Resistance and Support
Pivot 8023.67
Resistance
First Resistance
8325.34
Second Resistance
8560.67
Third Resistance
8862.34
Support
First Support
7788.34
Second Support
7486.67
Third Support
7251.34
Astrazeneca Pharma India Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 10 2026 | 8259 | 8090 | -1.23% | 8259 | 7722 |
| Fri Aug 07 2026 | 8129 | 8191 | 1.43% | 8209.5 | 8050 |
| Thu Aug 06 2026 | 8099 | 8075.5 | -0.41% | 8124.5 | 8050 |
Astrazeneca Pharma India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Astrazeneca Pharma India News
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
AstraZeneca Pharma India reported strong Q1 FY27 results, with revenue up 30% YoY to Rs.682.8 crore and profit after tax of Rs.50.7 crore. The company also announced key regulatory approvals for therapies like Acalabrutinib and Trastuzumab deruxtecan.
Aug 11 2026 00:43:12
AstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
AstraZeneca Pharma India Ltd received permission to import, sell, and distribute its drug Enhertu® for an additional HER2-positive breast cancer indication in India. This approval paves the way for marketing the drug in the country for this specific patient group.
Aug 08 2026 11:34:06
Read More
Astrazeneca Pharma India Management
| Name | Position |
|---|---|
| Shilpa Divekar Nirula | Chairperson |
| Revathy Ashok | Non Executive Independent Director |
Astrazeneca Pharma India Similar Stocks
Acutaas Chemicals Ltd.
3282.00
0.00 (0.00%)
Pfizer Ltd.
4877.60
0.00 (0.00%)
Granules India Ltd.
855.15
0.00 (0.00%)
Caplin Point Laboratories Ltd.
2623.80
0.00 (0.00%)
Eris Lifesciences Ltd.
1393.40
0.00 (0.00%)
Onesource Specialty Pharma Ltd.
1575.40
0.00 (0.00%)
Dr. Agarwal's Health Care Ltd.
560.70
0.00 (0.00%)
Poly Medicure Ltd.
1772.40
0.00 (0.00%)
Cohance Lifesciences Ltd.
447.00
0.00 (0.00%)
Natco Pharma Ltd.
910.50
0.00 (0.00%)
Astrazeneca Pharma India FAQs
The Buying Price of Astrazeneca Pharma India share is 8090 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Astrazeneca Pharma India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astrazeneca Pharma India, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Astrazeneca Pharma India shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Astrazeneca Pharma India shares is 0. Useful to assess the stock's value relative to its book value.
To assess Astrazeneca Pharma India’s valuation compare Sector P/E, P/B which are 64.83 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Astrazeneca Pharma India is 20225.00 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Astrazeneca Pharma India share price is 9849.50 & 7551.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Astrazeneca Pharma India belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
